Secretion of functional interferon by the type 3 secretion system of enteropathogenic Escherichia coli

Irina Rostovsky,Uri Wieler,Alona Kuzmina,Ran Taube and Neta Sal-Man
DOI: https://doi.org/10.1186/s12934-024-02397-y
IF: 6.352
2024-06-02
Microbial Cell Factories
Abstract:Type I interferons (IFN-I)—a group of cytokines with immunomodulatory, antiproliferative, and antiviral properties—are widely used as therapeutics for various cancers and viral diseases. Since IFNs are proteins, they are highly susceptible to degradation by proteases and by hydrolysis in the strong acid environment of the stomach, and they are therefore administered parenterally. In this study, we examined whether the intestinal bacterium, enteropathogenic Escherichia coli (EPEC), can be exploited for oral delivery of IFN-Is. EPEC survives the harsh conditions of the stomach and, upon reaching the small intestine, expresses a type III secretion system (T3SS) that is used to translocate effector proteins across the bacterial envelope into the eukaryotic host cells.
biotechnology & applied microbiology
What problem does this paper attempt to address?